Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody [1]

Blood

Volumn 107, Issue 7, 2006, Pages 3009-3010

  Thaunat, Olivier ^a   Mamzer Bruneel, Marie France ^b   Agbalika, Felix ^b   Valensi, Françoise ^b   Venditto, Marcia ^b   Lebbe, Céleste ^b   Frances, Camille ^b   Kania, Romain ^b   Chatenoud, Lucienne ^b   Antoine, Corinne ^b   Kaveri, Srinivas ^b   Kreis, Henri ^b   Morelon, Emmanuel ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 6; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CADAVER KIDNEY; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; GRANULOCYTE PRECURSOR; HUMAN; HUMAN HERPESVIRUS 8; KIDNEY ALLOGRAFT; KIDNEY FAILURE; LABORATORY TEST; LETTER; MALE; MYELOBLAST; NEPHROSCLEROSIS; PANCYTOPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL EXAMINATION; PLASMACYTOSIS; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 33645511833     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-08-3213     Document Type: Letter

References (8)

1. Luppi M, Barozzi P, Rasini V, et al. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation. 2002;74:131-132.
2. Luppi M, Barozzi P, Schulz TF, et al. Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood. 2000;96:2355-2357.
3. Cuzzola M, Irrera G, Iacopino O, et al. Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantation. Clin Infect Dis. 2003;37:e102-e106.
4. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med. 2000;343:1378-1385.
5. Maloney DG, Liles TM, Czerwinski DK, et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood. 1994;84:2457-2466.
6. Cannon JS, Ciufo D, Hawkins AL, et al. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol. 2000;74:10187-10193.
7. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406-1412.
8. Milone M, Tsai DE, Hodinka RL, et al. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell directed therapy. Blood. 2005;105;994-996.